Computational Analysis of Artimisinin Derivatives on the Antitumor Activities

doi:10.1007/s13659-017-0142-x

Natural Products and Bioprospecting

2017, Vol. 7

Issue (6) : 433-443 DOI: 10.1007/s13659-017-0142-x

ORIGINAL ARTICLES

Computational Analysis of Artimisinin Derivatives on the Antitumor Activities

Hui Liu, Xingyong Liu, Li Zhang

School of Chemical Engineering, Sichuan University of Science & Engineering, Zigong, China

Abstract
References
Related Articles
Metrics

Download: PDF(5569 KB) HTML ()
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract The study on antitumor activities of artemisinin and its derivatives has been closely focused on in recent years. Herein, 2D and 3D QSAR analysis was performed on the basis of a series of artemisinin derivatives with known bioactivities against the non-small-cell lung adenocarcinoma A549 cells. Four QSAR models were successfully established by CoMSIA, CoMFA, topomer CoMFA and HQSAR approaches with respective characteristic values q²=0.567, R²=0.968, ONC=5; q²=0.547, R²=0.980, ONC=7; q²=0.559, R²=0.921, ONC=7 and q²=0.527, R²=0.921, ONC=6. The predictive ability of CoMSIA with r²=0.991 is the best one compared with the other three approaches, such as CoMFA (r²=0.787), topomer CoMFA (r²=0.819) and HQSAR (r²=0.743). The final QSAR models can provide guidance in structural modification of artemisinin derivatives to improve their anticancer activities.

Keywords QSAR CoMFA CoMSIA Topomer CoMFA HQSAR Artemisinin

Fund:We gratefully thank financial assistance from the Science and Technology Innovation Talent Project of Sichuan province (Grant Number 2016073).

Corresponding Authors: Hui Liu E-mail: 18227755087@163.com

Issue Date: 09 December 2017

	Service

	E-mail this article
	E-mail Alert
	RSS
	Articles by authors

	Hui Liu
	Xingyong Liu
	Li Zhang

Trendmd:

Cite this article:

Hui Liu,Xingyong Liu,Li Zhang. Computational Analysis of Artimisinin Derivatives on the Antitumor Activities[J]. Natural Products and Bioprospecting, 2017, 7(6): 433-443.

URL:

http://npb.kib.ac.cn/EN/10.1007/s13659-017-0142-x OR http://npb.kib.ac.cn/EN/Y2017/V7/I6/433

W. Chen, R. Zheng, P.D. Baade, S. Zhang, H. Zeng, F. Bray, A. Jemal, X.Q. Yu, J. He, CA Cancer J. Clin. 66, 115–132 (2016)2. D.A. Deng, J.C. Cai, Youji Huaxue 11, 540–543 (1991)3. H. Lai, N.P. Singh, Cancer Lett. 91, 41–46 (1995)4. N.P. Singh, H. Lai, Life Sci. 70, 49–56 (2001)5. L.H. Binh, N.T.T. Van, V.T. Kien, N.T.T. My, L. Van Chinh, N.T. Nga, H.X. Tien, D.T. Thao, T.K. Vu, Med. Chem. Res. 25, 738–750 (2016)6. C.C. Xu, T. Deng, M.L. Fan, W.B. Lv, J.H. Liu, B.Y. Yu, Eur. J. Med. Chem. 107, 192–203 (2016)7. A.G. Blazquez, M. Fernandez-Dolon, L. Sanchez-Vicente, A.D. Maestre, A.B. Gomez-San Miguel, M. Alvarez, M.A. Serrano, H. Jansen, T. Efferth, J.J. Marin, M.R. Romero, Bioorg. Med. Chem. 21, 4432–4441 (2013)8. M.P. Crespo-Ortiz, M.Q. Wei, J. Biomed. Biotechnol. 2012, 247597 (2012)9. G.H. Posner, S.B. Park, L. Gonzalez, D. Wang, J.N. Cumming, D. Klinedinst, T.A. Shapiro, M.D. Bachi, J. Am. Chem. Soc. 118, 3537–3538 (1996)10. F. Cheng, J. Shen, X. Luo, W. Zhu, J. Gu, R. Ji, H. Jiang, K. Chen, Bioorg. Med. Chem. 10, 2883–2891 (2002)11. M.E. Saeed, O. Kadioglu, E.J. Seo, H.J. Greten, R. Brenk, T. Efferth, Anticancer Res. 35, 1929–1934 (2015)12. R.D. Cramer, J. Med. Chem. 46, 374–388 (2003)13. W. Tong, D.R. Lowis, R. Perkins, Y. Chen, W.J. Welsh, D.W. Goddette, T.W. Heritage, D.M. Sheehan, J. Chem. Inf. Comput. Sci. 38, 669–677 (1998)14. M.A. Avery, M. Alvim-Gaston, C.R. Rodrigues, E.J. Barreiro, F.E. Cohen, Y.A. Sabnis, J.R. Woolfrey, J. Med. Chem. 45, 292–303 (2002)15. D.K. Yadav, S. Dhawan, A. Chauhan, T. Qidwai, P. Sharma, R.S. Bhakuni, O.P. Dhawan, F. Khan, Curr. Drug Targets 15, 753–761 (2014)16. Y. Li, J.-M. Wu, F. Shan, G.-S. Wu, J. Ding, D. Xiao, J.-X. Han, G. Atassi, S. Leonce, D.-H. Caignard, P. Renard, Biorg. Med. Chem. 11, 977–984 (2003)17. J.M. Wu, F. Shan, G.S. Wu, Y. Li, J. Ding, D. Xiao, J.X. Han, G. Atassi, S. Leonce, D.H. Caignard, P. Renard, Eur. J. Med. Chem. 36, 469–479 (2001)18. K. Roy, Exp. Opin Drug Discov. 2, 1567–1577 (2007)19. A. Gaurav, R. Singh, Med. Chem. (Shariqah (United Arab Emirates)) 8, 894–912 (2012)20. M. Lalit, R.P. Gangwal, G.V. Dhoke, M.V. Damre, K. Khandelwal, A.T. Sangamwar, J. Mol. Struct. 1049, 315–325 (2013)21. A. Heidari, M.H. Fatemi, Chem. Biol. Drug Des. 89, 918–931 (2017)22. K.Z. Myint, X.Q. Xie, Int. J. Mol. Sci. 11, 3846–3866 (2010)

[1]	Mounir Tilaoui, Hassan Ait Mouse, Abdeslam Jaafari, Abdelmajid Zyad. Differential Effect of Artemisinin Against Cancer Cell Lines[J]. Natural Products and Bioprospecting, 2014, 4(3): 189-196.
[2]	Elmar Breuer, Thomas Efferth. Treatment of Iron-Loaded Veterinary Sarcoma by Artemisia annua[J]. Natural Products and Bioprospecting, 2014, 4(2): 113-118.
[3]	Shilpi PAUL, Madan M GUPTA, Suman P S KHANUJA. *Maintaining the artemisinin content through direct and indirect in vitro* regeneration and their assessment of variations with the field grown mother plants of Artemisia annua L.**[J]. Natural Products and Bioprospecting, 2012, 2(5): 194-199.

Viewed

Full text

Abstract

Cited

Shared

Discussed